Status of head and neck brachytherapy in Spain in 2022.

Autor: Guinot JL; Radiation Oncology Department, Fundacion Instituto Valenciano de Oncologia (I.V.O.), C/Profesor Beltran Baguena 8, 46009, Valencia, Spain. jguinot@fivo.org., Diezhandino P; Radiation Oncology Department, Hospital Clinico Universitario de Valladolid, Valladolid, Spain., de Frutos JM; Radiation Oncology Department, Hospital Clinico Universitario de Valladolid, Valladolid, Spain., Fuentemilla N; Radiation Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain., Gonzalez-Perez V; Department of Medical Physics, Fundacion Instituto Valenciano de Oncologia (I.V.O.), Valencia, Spain., Gutierrez C; Department of Radiation Oncology, Institut Català d'Oncologia, Barcelona, Spain., Herreros A; Radiation Oncology Department, Hospital Clínic Universitari, Barcelona, Spain., Martinez-Monge R; Department of Oncology, Clínica Universitaria de Navarra, CUN, Pamplona, Spain., Perez-Echagüen S; Radiation Oncology Department, CIBIR - Complejo Hospitalario San Pedro La Rioja, Logroño, Spain., Pino F; Department of Medical Physics, Institut Català d'Oncologia, Barcelona, Spain., Roldán S; Radiation Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Rovirosa A; Radiation Oncology Department, Hospital Clínic Universitari, Barcelona, Spain., Santos MA; Radiation Oncology Department, Fundacion Instituto Valenciano de Oncologia (I.V.O.), C/Profesor Beltran Baguena 8, 46009, Valencia, Spain., Sanz-Freire CJ; Medical Physics Department, CIBIR - Complejo Hospitalario San Pedro La Rioja, Logroño, Spain., Villafranca E; Radiation Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain.
Jazyk: angličtina
Zdroj: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Feb; Vol. 26 (2), pp. 456-460. Date of Electronic Publication: 2023 Aug 07.
DOI: 10.1007/s12094-023-03265-8
Abstrakt: Purpose: Brachytherapy (BT) has been used for many years for disease control in tumours of the head and neck area (H&N). It is currently performed with high dose rate (HDR) or pulsed dose rate (PDR), but its use has been reduced due to the implementation of new non-invasive external beam radiotherapy techniques such as intensity modulation (IMRT) and volumetric modulated arc therapy (VMAT) and the improvement of surgical techniques.
Methods: The Spanish Brachytherapy Group (GEB) has carried out a survey to find out the number of centres in Spain that continue to use BT in H&N and its indications and expectations for the future.
Results: The results were presented at the XX GEB Consensus Meeting held on October 21, 2022, in Valencia (Spain) and it was confirmed that, although there are fewer and fewer centres that use BT in H&N, there are still units with extensive experience in this technique that should be positioned as referral centres.
Conclusion: It is necessary to carry out continuous work with other specialities involved, such as H&N surgeons, and other radiation oncologists, to improve the training of residents, both oncologists and medical physicists.
(© 2023. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).)
Databáze: MEDLINE
Externí odkaz: